AudioScholar Cardiology Weekly

Episode

• 
  This Week in Cardiology — Sep 14, 2026 15.09.2026 13mnt

  Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning acute coronary care and mechanical support, the diagnosis and treatment of heart failure with preserved ejection fraction, and a cluster of studies on cardiovascu… This week's papers: 1. Clinical Management of Myocardial Infarction. — Circulation 2026 2. Mechanical Circulatory Support for Complex High-Risk Indicated Percutaneous Coronary Intervention: Network Meta-Analysis of Randomized Trials. — Journal of the American Heart Association 2026 3. PET, Proteomics, and Immunophenotyping of Arterial Inflammation and Checkpoint Inhibition. — JAMA Cardiology 2026 4. Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial. — Nature Medicine 2026 5. Exercise stress echocardiography for diagnosis of heart failure with preserved ejection fraction: a multicentre study. — European Heart Journal 2026 6. Phenotype-specific prognostic implications of pulse pressure in heart failure. — European Journal of Heart Failure 2026 7. Simultaneous derivation, validation, and comparison of predictor hazard ratios for cardiovascular risk prediction equations in patients with diabetes from high… — BMJ 2026 8. Nighttime light exposure and cardiac structure and function. — European Heart Journal 2026 9. Designing Cardiovascular Outcomes Trials in Clonal Hematopoiesis of Indeterminate Potential. — JAMA Cardiology 2026 10. Outcomes of Asian and Caucasian patients with type A aortic intramural haematoma: a multicentre registry analysis. — Heart 2026 Listen at https://audioscholar.cc/episode/p9uyd43dn8
• 
  This Week in Cardiology — Sep 7, 2026 08.09.2026 11mnt

  Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning revascularisation — from the operating theatre to the cath lab — heart failure and decongestion, and risk stratification across arrhythmia, valve disease and occu… This week's papers: 1. Long-Term Outcomes Following Bilateral vs Single Internal Thoracic Artery Grafts: A Secondary Analysis of a Randomized Clinical Trial. — JAMA Cardiology 2026 2. Geographic heterogeneity in outcomes of intravascular ultrasound-guided vs angiography-guided percutaneous coronary intervention: a meta-analysis of randomized… — European Heart Journal 2026 3. Intracoronary imaging in percutaneous coronary intervention: why, when, how and which from large, randomized trials. — Nature Reviews Cardiology 2026 4. Direct transfer to primary percutaneous coronary intervention centres following out-of-hospital cardiac arrest: longer term outcomes and influences on survival. — Heart 2026 5. Contemporary decongestion strategies in acute heart failure: an individual patient data analysis of three randomized controlled trials. — European Journal of Heart Failure 2026 6. Type 2 diabetes and chronic kidney disease combinations in heart failure across the ejection fraction spectrum: clinical associations, medication use, and caus… — European Journal of Heart Failure 2026 7. Ischaemic stroke in atrial flutter vs fibrillation: a Finnish nationwide study. — European Heart Journal 2026 8. Targeted vitamin D supplementation and major adverse cardiovascular events after myocardial infarction: the TARGET-D trial. — European Heart Journal 2026 9. Early and Late TAVI Outcomes in Aortic Stenosis with Transthyretin Cardiac Amyloidosis: A Systematic Review. — European Journal of Heart Failure 2026 10. Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities: A Scientific Statement From the American College of Cardiology… — Journal of the American College of Cardiology 2026 Listen at https://audioscholar.cc/episode/tuffd4vqh7
• 
  This Week in Cardiology — Aug 31, 2026 01.09.2026 12mnt

  Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning structural heart intervention, revascularization and imaging strategy in coronary disease, antithrombotic therapy after acute coronary syndromes, device-based rhy… This week's papers: 1. Tricuspid-Valve Intervention in Heart Failure — New England Journal of Medicine 2026 2. Timing of PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation — New England Journal of Medicine 2026 3. Complete Revascularization Guided by Functional Coronary Angiography in STEMI — New England Journal of Medicine 2026 4. Targeted left ventricular lead placement in biventricular pacing for heart failure: a national, multicentre, double-blind, randomised controlled trial in Denma… — The Lancet 2026 5. Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest Pain — New England Journal of Medicine 2026 6. Pacemaker-implantation and atrioventricular-node ablation vs pulmonary vein isolation for elderly patients with persistent atrial fibrillation: the ABLATE vers… — European Heart Journal 2026 7. Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event — New England Journal of Medicine 2026 8. Prasugrel versus Ticagrelor in Acute Coronary Syndromes — New England Journal of Medicine 2026 9. Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients — New England Journal of Medicine 2026 10. Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults — New England Journal of Medicine 2026 Listen at https://audioscholar.cc/episode/7eq3w93ye7
• 
  This Week in Cardiology — Aug 24, 2026 25.08.2026 11mnt

  Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning antithrombotic and structural decisions in atrial fibrillation and valve surgery, lipid management and residual risk, and a set of practical clinical reviews on s… This week's papers: 1. Vasoactive Agent Selection Strategies in the Management of Cardiogenic Shock — Circulation 2026 2. Prophylactic Surgical Left Atrial Appendage Closure in Bioprosthetic Aortic Valve Replacement: Short-Term Outcomes of Randomized Controlled LAA-CLOSURE Trial — Journal of the American Heart Association 2026 3. Clopidogrel Versus Dual-Antiplatelet Therapy for Long-Term Maintenance After Coronary Stenting in Ischemic and Bleeding Birisk Patients With Acute Coronary Syn… — Journal of the American Heart Association 2026 4. Diagnosis and management of acute hyperkalaemia — BMJ 2026 5. Clinical Benefits Associated With Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia — Journal of the American Heart Association 2026 6. Residual Atherosclerotic Cardiovascular Disease Risk in Statin Users: A Systematic Review and Meta-Analysis — Journal of the American Heart Association 2026 7. Sodium-Glucose Cotransporter-2 Inhibition in Patients With Newly Diagnosed Atrial Fibrillation: A Nationwide Cohort Study — Journal of the American Heart Association 2026 8. Artificial Intelligence-Driven Angiographic Quantification of Fractional Flow Reserve: Proof-of-Concept Validation Study — Journal of the American Heart Association 2026 9. Severe Infections as a Novel Risk-Enhancing Factor for Incident Heart Failure — Journal of the American Heart Association 2026 10. Postural Orthostatic Tachycardia Syndrome (POTS): A Review — JAMA 2026 Listen at https://audioscholar.cc/episode/z8vfasmaa5
• 
  This Week in Cardiology — Aug 17, 2026 18.08.2026 11mnt

  Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning risk stratification with biomarkers and body measurements, imaging to guide decisions in chest pain and cardiomyopathy, and therapeutics ranging from finerenone i… This week's papers: 1. Finerenone and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction. — European Journal of Heart Failure 2026 2. Vutrisiran Treatment and Changes in Cardiac Parameters and Amyloid Burden Assessed by Cardiovascular MRI. — JAMA Cardiology 2026 3. Cold and Room-Temperature Platelets in Cardiac Surgery: The CHIPS Randomized Clinical Trial. — JAMA 2026 4. Coronary calcium scoring in the evaluation of stable chest pain in general practice: a cluster-randomised trial. — Heart 2026 5. NT-proBNP in relation to clinical characteristics and cardiovascular outcomes in non-anticoagulated patients with atrial fibrillation. — Heart 2026 6. Longitudinal Changes in Heart Stress and the Risk for Cardiovascular Disease and Mortality in Older Adults: An Observational Study. — Annals of Internal Medicine 2026 7. Risk Reclassification Beyond BMI by Waist Circumference and Waist-to-Hip Ratio Across 9 Cardiovascular Outcomes: Results From the Cross-Cohort Collaboration. — Journal of the American College of Cardiology 2026 8. Oral anticoagulants, cognition, and clinical outcomes in atrial fibrillation and Alzheimer's disease: a Swedish nationwide study. — European Heart Journal 2026 9. Gender-related risk of myocardial infarction and subclinical coronary atherosclerosis: a Danish population cohort study. — European Heart Journal 2026 10. The Pediatric Pulmonary Hypertension International Risk Score: A Prediction Model for Outcomes Using Machine Learning. — Circulation 2026 Listen at https://audioscholar.cc/episode/3kshes2mmp
• 
  This Week in Cardiology — Aug 10, 2026 11.08.2026 11mnt

  Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning heart failure — from what actually drives the benefit of our drugs to how outcomes have changed over a decade — plus anticoagulation and thrombotic risk in two ve… This week's papers: 1. Cognitive Impairment and Frailty in Older Adults With Cardiovascular Disease: 2026 ACC Scientific Statement: A Report of the American College of Cardiology. — Journal of the American College of Cardiology 2026 2. Real-World Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Mitral Stenosis: A Target Trial Emul… — Annals of Internal Medicine 2026 3. Effects of pharmacological blood pressure lowering in heart failure with mildly reduced or preserved ejection fraction: a meta-analysis. — Heart 2026 4. Utility of Prognostic Staging Systems in Transthyretin Amyloidosis Cardiomyopathy in the Era of Available Disease-Modifying Treatment. — Journal of the American Heart Association 2026 5. Temporal comparison of clinical practice and outcomes in heart failure: the JROADHF and JROADHF-NEXT studies. — European Heart Journal 2026 6. How Would You Manage Perioperative Cardiovascular Risk for Noncardiac Surgery in This Patient With Complex Comorbidity? Grand Rounds Discussion From Beth Israe… — Annals of Internal Medicine 2026 7. Real-World Diagnostic Performance of Repeat Transthoracic Echocardiography Within a Multimodality Imaging Approach in Patients With Suspected Infective Endocar… — Journal of the American Heart Association 2026 8. Early Decline in Serum Haptoglobin During Impella CP Support Compared With Intra-Aortic Balloon Pump in Cardiogenic Shock: A Single-Center Observational Study. — Journal of the American Heart Association 2026 9. Endometriosis and long-term risk of venous thromboembolism: a Danish nationwide study. — European Heart Journal 2026 10. General and Exertional Fatigue, Quality of Life, and Risk of Incident Clinical Heart Failure in Those With Pre-heart Failure in the ARIC Study. — Journal of the American Heart Association 2026 Listen at https://audioscholar.cc/episode/n687zb6983
• 
  This Week in Cardiology — Aug 3, 2026 04.08.2026 10mnt

  Welcome to This Week in Cardiology. This week we're covering nine notable papers spanning interventional and surgical revascularisation, cardiomyopathy imaging and pharmacotherapy, and the harder questions of anticoagulation, mechanical support, and… This week's papers: 1. Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised co… — Lancet 2026 2. Left Ventricular Hypertrabeculation and Prognosis in Dilated Cardiomyopathy. — Circulation 2026 3. Long-Term Impact of Aficamten on Patient-Reported Outcome Measures in Obstructive Hypertrophic Cardiomyopathy: Results From FOREST-HCM. — European Journal of Heart Failure 2026 4. Impact of Drug-Coated Balloon Inflation Time on Outcome After Percutaneous Coronary Intervention: An Observational Study From SCAAR. — Journal of the American Heart Association 2026 5. Stopping Oral Anticoagulation After Catheter Ablation for Atrial Fibrillation in Patients With High Risk of Stroke: STOP-OAC Study. — Journal of the American Heart Association 2026 6. Left Ventricular Unloading With Impella Versus Intra-Aortic Balloon Pump in Cardiogenic Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation. — Journal of the American Heart Association 2026 7. Association Between Heart Failure Medications and Outcomes in Patients With Cardiac Sarcoidosis and Left Ventricular Systolic Dysfunction: Insights From ILLUMI… — Journal of the American Heart Association 2026 8. Side effects in hypertension treatment: a pharmacogenomic analysis. — European Heart Journal 2026 9. Mineralocorticoid receptor overactivation in heart failure with preserved ejection fraction. — European Heart Journal 2026 Listen at https://audioscholar.cc/episode/cbd4fc6ufm
• 
  This Week in Cardiology — Jul 31, 2026 31.07.2026 12mnt

  Welcome to This Week in Cardiology. This week we're covering six notable papers spanning advanced surgical and interventional outcomes, tailored pharmacotherapy in heart failure phenotypes, and the management of structural heart disease. Let's dive i… This week's papers: 1. Dapagliflozin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial — JAMA 2026 2. Antithrombotic treatment for migraine in patients with patent foramen ovale: multicentre, randomised, active controlled, open label trial — BMJ (Clinical research ed.) 2026 3. Catheter ablation in end-stage heart failure with atrial fibrillation: an hierarchical endpoint analysis of the CASTLE-HTx trial — European Journal of Heart Failure 2026 4. Evaluation and management of heart failure patients with liver disease: European Journal of Heart Failure International Expert Position Paper — European Journal of Heart Failure 2026 5. Target Versus Below-Target Dose ACE Inhibitors in U.S. Veterans with HFpEF: Differential Outcomes by CKD Status — European Journal of Heart Failure 2026 6. Survival following aortic valve surgery for prosthetic valve endocarditis: a SWEDEHEART study — Heart (British Cardiac Society) 2026 Listen at https://audioscholar.cc/episode/e3ugt8fs3w
• 
  This Week in Cardiology — Jul 20, 2026 21.07.2026 9mnt

  Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning major updates in lipid and preventive guidelines, new insights into heart failure management and phenotyping, and advances in vascular and coronary interventions.… This week's papers: 1. Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin Therapy — JAMA 2026 2. Global Cardiology Groups Issue New Universal Definition of Heart Failure — JAMA 2026 3. Drug-coated balloons versus drug-eluting stents for de novo coronary lesions: a systematic review and meta-analysis of randomised trials — Heart 2026 4. Initiation, Adherence, and Persistence to Guideline-Directed Medical Therapy After Heart Failure Hospitalization — JAMA Internal Medicine 2026 5. What to Know About the First CKM Syndrome Guidelines — JAMA 2026 6. Cardiovascular Risk Reclassification With the 2026 Dyslipidemia Guideline — JAMA 2026 7. Peripheral artery disease: advances in medical therapy — European Heart Journal 2026 8. Caffeine and Cardiovascular Disease: A Scientific Statement From the American Heart Association — Circulation 2026 9. Diagnostic Approach to Cardiac Sarcoidosis — Circulation 2026 10. Does Characterization of Phenotypic Heterogeneity Provide Mechanistic Insights or Influence the Response to Treatment? Experience in Positive and Neutral Trial… — Circulation 2026 Listen at https://audioscholar.cc/episode/42zd8ggmrd
• 
  This Week in Cardiology — Jul 13, 2026 14.07.2026 9mnt

  Welcome to This Week in Cardiology. This week we're covering nine notable papers spanning advanced heart failure management, novel cardiovascular risk factors, and evolving frameworks for lifelong care. Let's dive in. We begin in the realm of advanc… This week's papers: 1. Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized Trial. — Circulation 2026 2. Comparison of Outcomes of Leadless Versus Transvenous Pacemakers Following Tricuspid Valve Surgery. — Journal of the American Heart Association 2026 3. First Italian multicentre registry for Mechanically Assisted Circulatory Support (ITAMACS) report: 12-year experience of over 1000 durable LVAD patients. — European Journal of Heart Failure 2026 4. World Heart Federation Roadmap on cardiac rehabilitation: a pathway to lifelong cardiovascular health. — Nature Reviews Cardiology 2026 5. Transforming Pulmonary Arterial Hypertension: Key Milestones and Future Perspectives. — Circulation 2026 6. Longitudinal Changes in Frailty and Major Adverse Cardiovascular Events in Patients With Coronary Heart Disease. — Journal of the American Heart Association 2026 7. Association Between Endometriosis and Cardiovascular Disease: Insights From the UK Biobank. — Journal of the American Heart Association 2026 8. Serum transthyretin as a staging biomarker in ATTR cardiomyopathy: promise, limitations, and the path forward. — European Journal of Heart Failure 2026 9. Causes of congenital heart disease: an integrative narrative review. — Heart 2026 Listen at https://audioscholar.cc/episode/pg8xj6k9y6
• 
  This Week in Cardiology — Jul 8, 2026 08.07.2026 8mnt

  Welcome to This Week in Cardiology. This week we're covering notable publications spanning advanced risk stratification in heart failure and hypertrophic cardiomyopathy, anticoagulation strategies in mechanical circulatory support, and the clinical n… This week's papers: 1. Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-lab… — Lancet 2026 2. Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association. — Circulation 2026 3. Natural History of Asymptomatic Phenotypically Mild HCM: Insights From the SHaRe Registry. — Journal of the American College of Cardiology 2026 4. Proteomic markers enhance mortality prediction in heart failure. — European Heart Journal 2026 Listen at https://audioscholar.cc/episode/fumey2xge7
• 
  This Week in Cardiology — Jun 30, 2026 30.06.2026 11mnt

  Welcome to This Week in Cardiology. This week we are covering eight notable papers spanning major updates in heart failure definitions, evolving antithrombotic and antiplatelet strategies, and precision cardio-oncology. Let us dive in. We begin with… This week's papers: 1. AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026) — European Heart Journal 2026 2. Antiplatelet Therapy in the Management of Atherosclerotic Cardiovascular Disease: 2026 ACC Scientific Statement: A Report of the American College of Cardiology — Journal of the American College of Cardiology 2026 3. Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events: 2026 ACC Scientific Statement: A Report of the American College of Cardiol… — Journal of the American College of Cardiology 2026 4. Weight loss, exercise haemodynamics, and health status with incretin therapy for heart failure with preserved ejection fraction and obesity — European Heart Journal 2026 5. Cliramitug for depletion of cardiac amyloid transthyretin: long-term follow-up of the NI006-101 trial — Nature Medicine 2026 6. High serum transthyretin concentrations identify a low likelihood of advanced myocardial amyloid burden in suspected ATTR cardiomyopathy — European Journal of Heart Failure 2026 7. Cardiac remodelling and dysfunction in cancer patients receiving cardiotoxic therapies: proteomic and metabolomic profiling — European Heart Journal 2026 8. Inclusive cardiovascular care for sexual and gender minority populations — Nature Reviews Cardiology 2026 Listen at https://audioscholar.cc/episode/ekr7nu7hjr
• 
  This Week in Cardiology — Jun 22, 2026 23.06.2026 13mnt

  Welcome to This Week in Cardiology. This week we're covering 9 notable papers spanning advanced heart failure management, novel interventional strategies for hypertension and arrhythmias, and critical updates in preventive cardiology and cardiovascul… This week's papers: 1. Interaction of heart failure with chronic kidney disease, liver disease and cancer: the need for systems cardiology. — European Heart Journal 2026 2. Perioperative Anemia and Patient Blood Management in Cardiac Surgery: A Scientific Statement From the American Heart Association. — Circulation 2026 3. Adjunctive posterior wall isolation for persistent and long-standing persistent atrial fibrillation: the CORNERSTONE AF trial. — European Heart Journal 2026 4. Combined hepatorenal denervation for hypertension and cardiometabolic disease: a first-in-human study. — European Heart Journal 2026 5. Excess Cardiovascular Mortality Among Black Americans, 2000-2024: A JACC Progress Report. — Journal of the American College of Cardiology 2026 6. Coronary artery calcium on chest CT scans: from incidental finding to mandatory reporting. — Nature Reviews Cardiology 2026 7. Strategies for Optimizing Heart Failure Care in the Older Adult: A Scientific Statement From the American Heart Association. — Circulation 2026 8. Efficacy of a Voice Biomarker for the Prediction of Heart Failure Hospitalisation: Results from the Telemedical Interventional Management in Heart Failure III… — European Journal of Heart Failure 2026 9. Clinical and Cardiac Magnetic Resonance Phenotype of Probable Viral versus Probable Immune-mediated Acute Myocarditis. — European Journal of Heart Failure 2026 Listen at https://audioscholar.cc/episode/mzaw6gzhxv
• 
  This Week in Cardiology — Jun 15, 2026 16.06.2026 11mnt

  Welcome to This Week in Cardiology. This week we're covering 9 notable papers spanning interventional cardiology and device updates, strategies for optimizing medical therapy and risk stratification, and a look at managing special populations with un… This week's papers: 1. Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association. — Circulation 2026 2. Randomized Controlled Trial of Internet-Delivered Cognitive Behavioral Therapy After Myocardial Infarction With Nonobstructive Coronary Arteries or Takotsubo S… — Journal of the American Heart Association 2026 3. Three-Year Durability of Radiofrequency Renal Denervation: SPYRAL HTN-ON MED. — Journal of the American Heart Association 2026 4. Optimal Antithrombotic Therapy for Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis. — Journal of the American Heart Association 2026 5. Sex Differences in Clinical Outcomes and Loss of Life Expectancy After Aortic Valve Surgery for Infective Endocarditis: A SWEDEHEART Study. — Journal of the American Heart Association 2026 6. Great debate: surgical aortic valve replacement is first choice for aortic stenosis in patients with a life expectancy beyond 5 years. — European heart journal 2026 7. Cholesterol-lowering therapy from childhood/adolescence and long-term outcomes in familial hypercholesterolaemia: the SAFEHEART study. — European heart journal 2026 8. Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Lab… — Circulation 2026 9. Albuminuria and heart failure. — European heart journal 2026 Listen at https://audioscholar.cc/episode/ege3j957nc
• 
  This Week in Cardiology — Jun 8, 2026 09.06.2026 10mnt

  Welcome to This Week in Cardiology. This week we're covering 9 notable papers spanning major advances in cardio-renal protection, new strategies for secondary prevention in atherosclerotic disease, and fresh insights into the lifelong management of s… This week's papers: 1. Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants. — Nature medicine 2026 2. Survivors of Cyanotic Congenital Heart Disease: A Review. — JAMA 2026 3. Structured Telehealth Community Health Worker-Clinician Feedback and Diabetes Outcomes: A Randomized Clinical Trial. — JAMA internal medicine 2026 4. Activation of HIF2 in Cardiac Vasculature Leads to Arterial Remodeling, Dilation, Thrombosis, and Inflammation, Recapitulating Cardiac Involvement in Kawasaki… — Circulation 2026 5. Prevalence and prognostic role of untreated moderate-to-severe tricuspid regurgitation: a systematic review and meta-analysis. — European journal of heart failure 2026 6. Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY). — Lancet (London, England) 2026 7. P2Y12 inhibitor monotherapy after abbreviated dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysis. — European heart journal 2026 8. Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REA… — European heart journal 2026 9. Finerenone in Persons with Chronic Kidney Disease without Diabetes. — The New England journal of medicine 2026 Listen at https://audioscholar.cc/episode/bpmgg9pfsu
• 
  This Week in Cardiology — Jun 6, 2026 06.06.2026 12mnt

  Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning the optimization of medical therapy for atherosclerotic disease, the expanding role of finerenone in chronic kidney disease, new insights from advanced imaging an… This week's papers: 1. P2Y12 inhibitor monotherapy after abbreviated dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysis. — European heart journal 2026 3. Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REA… — European heart journal 2026 4. Finerenone in Persons with Chronic Kidney Disease without Diabetes. — The New England journal of medicine 2026 5. Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial. — JAMA 2026 6. Cardiac Lipid Metabolism: Cells, Metabolites, and Rhythms. — Circulation research 2026 7. Incremental Prognostic Value of Subendocardial Myocardial Flow Reserve in Patients With Normal Perfusion. — Circulation 2026 8. ATAD3A Limits Aortic Dissection via Mito-Lysosome Contacts and Lipoylation. — Circulation research 2026 9. Safety of low lipoprotein(a) levels: the FOURIER trial. — European heart journal 2026 10. Estimating the Effects of MTEER in U.S. Practice: A Transportability Analysis of the COAPT Trial. — Journal of the American College of Cardiology 2026 Listen at https://audioscholar.cc/episode/tsamessqwc
• 
  This Week in Cardiology — May 28, 2026 28.05.2026 17mnt

  Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning heart failure management, new insights into antithrombotic and lipid-lowering drugs, important findings in arrhythmia, and the practicalities of clinical practice… This week's papers: 1. Adverse Effects and Treatment Discontinuation of Blood Pressure-Lowering Drugs and Combinations: A Network Meta-Analysis. — JAMA 2026 2. Optimal serum potassium concentrations in heart failure: an individual patient data meta-analysis. — European heart journal 2026 3. Stem-Cell-Derived Biologic Ventricular Assist Tissue in Heart Failure. — The New England journal of medicine 2026 4. Efficacy and Safety of Prasugrel, Ticagrelor, or Clopidogrel After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis. — JAMA cardiology 2026 5. Bempedoic Acid and Venous Thromboembolism Risk Among Statin-Intolerant Patients: A Post Hoc Analysis of the CLEAR Outcomes Randomized Clinical Trial. — JAMA cardiology 2026 6. Clinical Diagnosis of Calcium Release Deficiency Syndrome in a Family With Sudden Cardiac Death. — JAMA cardiology 2026 7. Risk-Based Nurse-Managed Personalized Heart Failure Interventions: The ALLEVIATE-HF Trial. — Journal of the American College of Cardiology 2026 8. Roadmap to Revitalizing Academic Cardiovascular Medicine: A Perspective From the Association of Professors of Cardiology (APC) Emerging Leaders Group. — Journal of the American College of Cardiology 2026 9. Arrhythmias, dementia risk, and neurodegeneration: a cohort study. — European heart journal 2026 10. Targeting RUNX1 protects against diastolic dysfunction in a two-hit mouse model of heart failure with preserved ejection fraction. — Cardiovascular research 2026 Listen at https://audioscholar.cc/episode/zk6xvfkxyu
• 
  This Week in Cardiology — May 21, 2026 21.05.2026 12mnt

  Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning critical care and resuscitation, new insights into cardiomyopathies and vascular disease, and a look at the future of therapy from the world of basic science. Let… This week's papers: 1. Ambient fine particulate matter exposure and prognosis in patients with valvular heart disease. — Heart 2026 2. Coronary microvascular dysfunction and cardiovascular outcomes (Multicenter FLOW-CMD Registry): a prospective, multicentre cohort study in South Korea. — Lancet (London, England) 2026 3. Intrapericardially injected hydrogel loaded with stromal cell secretome microparticles improves post-infarction myocardial repair in pigs. — European heart journal 2026 4. Current state of knowledge on the epidemiology, aetiology, diagnosis, and management of heart involvement in eosinophilia. A Clinical Consensus Statement of th… — European journal of heart failure 2026 5. Macrophage EHD1 Promotes Inflammation and Stabilizes Sortilin to Accelerate Atherosclerosis. — Circulation research 2026 6. Cardiac Intensive Care Unit Appropriate Patient Selection and Triage: A Scientific Statement From the American Heart Association. — Circulation 2026 7. Resuscitation Quality Improvement Program for CPR Training and Cardiac Arrest Survival in Hospitals. — JAMA cardiology 2026 8. Sex and Age Specific Genetic Risk Across the Dilated and Arrhythmogenic Cardiomyopathy Spectrum: Insights From the SHaRe Registry. — Journal of the American College of Cardiology 2026 9. Observational Comparative Research in Cardiovascular and Brain Health and Disease: A Scientific Statement From the American Heart Association. — Circulation 2026 10. Identification of unannotated microproteins involved in endothelial cell homeostasis, dysfunction and vascular disease. — Cardiovascular research 2026 Listen at https://audioscholar.cc/episode/vvrecb864a
• 
  This Week in Cardiology — May 14, 2026 14.05.2026 12mnt

  Welcome to This Week in Cardiology. This week we're covering 10 notable papers spanning heart failure management, advances in structural and rhythm disorders, and new strategies in prevention. Let's dive in. Our first theme is the management of acut… This week's papers: 1. Contemporary Management of Acute Heart Failure: From Emergency Presentation to Long-Term Remission. — Journal of the American College of Cardiology 2026 2. Safe treatment of atrial fibrillation in the community (STAY): a pilot study of community-based care for low-risk patients with acute atrial fibrillation. — Heart 2026 3. Machine learning-guided risk stratification for Long QT Syndrome genetic variants with hiPSC-derived cardiomyocytes. — Cardiovascular research 2026 4. Clinical Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Among Older Patients Hospitalized for Heart Failure With Reduced Ejection Fraction. — Journal of the American Heart Association 2026 5. Surgical Versus Transcatheter Aortic Valve Replacement in Bicuspid Aortic Stenosis: 1-Year Clinical Outcomes in Patients Aged 65 Years and Older. — Journal of the American Heart Association 2026 6. Low-Density Lipoprotein Cholesterol Lowering With Inclisiran Plus Usual Care in Recent Acute Coronary Syndrome: VICTORION-INCEPTION, a Randomized, Controlled,… — Journal of the American Heart Association 2026 7. Closing the Gap: Examining Representation of Women in Ischemic Heart Disease Guideline Studies. — Journal of the American Heart Association 2026 8. Primer of conduction system pacing for the general cardiologist. — Heart 2026 9. Temporal trends in characteristics, management and prognosis of patients with acute heart failure through two repeated snapshots. — Heart 2026 10. Cancer and cardiovascular disease: converging burdens, shared challenges. — European heart journal 2026 Listen at https://audioscholar.cc/episode/4rtpqsg27v